Publications by authors named "Michael MacManus"

Claim this Profile
A
A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer.
Neil D Wallace, Mathias Bressel, Nick Hardcastle, Lachlan McIntosh, Nick Bucknell, Michael MacManus

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.
Eliza A Hawkes, Jodie B Palmer, Richard Khor, Sze Ting Lee, Melinda Burgess, Michael MacManus

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An International Lymphoma Radiation Oncology Group Study of Radiation Therapy for Bilateral Indolent Orbital Adnexal Lymphomas.
Krystel Tran, Dongryul Oh, Richard Tsang, Chang-Ok Suh, Hong In Yoon, Michael MacManus

Int J Radiat Oncol Biol Phys· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort Study.
Neil D Wallace, Jing Xie, Marliese Alexander, David Ball, Fiona Hegi-Johnson, Michael MacManus

Clin Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung Cancer.
Michael P MacManus, Elizabeth Prins, Jing Xie, Tim Akhurst, Rodney J Hicks

Int J Radiat Oncol Biol Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.
Daniel Erku, Joshua W D Tobin, John F Seymour, Michael MacManus, Paul Scuffham

EJHaem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
Michael P MacManus, John F Seymour, Hennes Tsang, Richard Fisher, Colm Keane

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy.
Samantha A Hershenfeld, Josuha W D Tobin, Victoria Shelton, Lourdes Calvente, Katherine Lajkosz, Michael MacManus

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Joshua W D Tobin, Greg Hapgood, Anna Johnston, Chan Y Cheah, Sze T Lee, Michael MacManus

Intern Med J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.
May Abdel-Wahab, C Norman Coleman, Jesper Grau Eriksen, Peter Lee, Ryan Kraus, Michael MacManus

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to COVID-19 vaccination imaged by PD-L1 PET scanning.
Michael P MacManus, Tim Akhurst, Sharon R Lewin, Fiona Hegi-Johnson

EJNMMI Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.
Neil D Wallace, Marliese Alexander, Jing Xie, David Ball, Fiona Hegi-Johnson, Michael MacManus

Lung Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
Fiona Hegi-Johnson, Stacey E Rudd, Christian W Wichmann, Tim Akhurst, Peter Roselt, Michael MacManus

Int J Radiat Oncol Biol Phys· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial.
Marliese Alexander, Sam Harris, Craig Underhill, Javier Torres, Sharad Sharma, Michael MacManus

JAMA Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC.
Michael MacManus, Laura Kirby, Benjamin Blyth, Owen Banks, Olga A Martin

Clin Transl Radiat Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 Trial.
Nicholas W Bucknell, Tomas Kron, Alan Herschtal, Nicholas Hardcastle, Louis Irving, Michael MacManus

Int J Radiat Oncol Biol Phys· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of lung doses in patients undergoing total body irradiation for haematological malignancies with and without lung shielding.
Peta Lonski, Michael MacManus, Belinda A Campbell, Greg Wheeler, Elena Ungureanu

J Med Imaging Radiat Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi.
Mario Levis, Belinda A Campbell, Fabio Matrone, Lavinia Grapulin, Anna Di Russo, Michael MacManus

Int J Radiat Oncol Biol Phys· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
Joanna Huang, Wasek Faisal, Margaret Brand, Shantelle Smith, Marliese Alexander, Michael MacManus

Med J Aust· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated radiosynthesis of [Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.
Christian W Wichmann, Stan Poniger, Nancy Guo, Peter Roselt, Stacey E Rudd, Michael MacManus

Nucl Med Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?
Belinda A Campbell, Rachel Brown, Alessandro Lambertini, Michael S Hofman, Mathias Bressel, Michael MacManus

Br J Haematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer.
Richard J Lobb, Kekoolani S Visan, Li-Ying Wu, Emma L Norris, Marcus L Hastie, Michael MacManus

Commun Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases.
Shankar Siva, Gavin Jones, Mathias Bressel, Mark Shaw, Sarat Chander, Michael MacManus

Int J Radiat Oncol Biol Phys· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Fiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, Tim Akhurst, Peter Roselt, Michael MacManus

BMJ Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study.
Sweet Ping Ng, Carlos E Cardenas, Houda Bahig, Baher Elgohari, Jihong Wang, Michael P MacManus

Curr Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis